AIM ImmunoTech Depreciation & Amortization 2011-2026 | AIM

Annual Depreciation & Amortization AIM ImmunoTech

2025	2024	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
37 K	37 K	38 K	659 K	665 K	735 K	856 K	948 K	1.12 M	941 K	665 K	671 K	643 K	465 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.12 M	37 K	606 K

Quarterly Depreciation & Amortization AIM ImmunoTech

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	10 K	-	-	-	9 K	-	-	-	11 K	-	29 K	20 K	10 K	-	484 K	325 K	162 K	-	500 K	340 K	173 K	-	557 K	380 K	194 K	-	658 K	444 K	216 K	-	739 K	504 K	261 K	-	854 K	576 K	300 K	-	663 K	458 K	180 K	-	500 K	332 K	167 K	-	504 K	350 K	179 K	-	469 K	296 K	149 K	-	322 K	198 K	112 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
854 K	9 K	324 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Aligos Therapeutics ALGS	930 K	$ 8.74	0.23 %	$ 86.4 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.38	0.09 %	$ 999 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.56	6.12 %	$ 401 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.05	4.45 %	$ 5.02 M	Israel
Aquestive Therapeutics AQST	548 K	$ 4.15	-0.95 %	$ 444 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 25.09	4.02 %	$ 3.19 B	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.48	0.68 %	$ 394 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Cabaletta Bio CABA	1.65 M	$ 3.26	1.87 %	$ 328 M	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 4.63	9.01 %	$ 312 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA